Antonella Riva, Eray Sahin, Greta Volpedo, Noemi Teresa Catania, Isabel Venara, Valentina Biagioli, Ganna Balagura, Elisabetta Amadori, Carmen De Caro, Emanuele Cerulli Irelli, Carlo Di Bonaventura, Federico Zara, Osman Ugur Sezerman, Emilio Russo, Pasquale Striano
{"title":"Medication-resistant epilepsy is associated with a unique gut microbiota signature","authors":"Antonella Riva, Eray Sahin, Greta Volpedo, Noemi Teresa Catania, Isabel Venara, Valentina Biagioli, Ganna Balagura, Elisabetta Amadori, Carmen De Caro, Emanuele Cerulli Irelli, Carlo Di Bonaventura, Federico Zara, Osman Ugur Sezerman, Emilio Russo, Pasquale Striano","doi":"10.1111/epi.18367","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>Dysfunction of the microbiota–gut–brain axis is emerging as a new pathogenic mechanism in epilepsy, potentially impacting on medication response and disease outcome. We investigated the composition of the gut microbiota in a cohort of medication-resistant (MR) and medication-sensitive (MS) pediatric patients with epilepsy.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Children with epilepsy of genetic and presumed genetic etiologies were evaluated clinically and subgrouped into MR and MS. Age-matched healthy controls (HCs) were also recruited. A food diary was used to evaluate nutritional habits, and the Rome IV questionnaire was used to record gastrointestinal symptoms. The microbiota composition was assessed in stool samples through 16S rRNA. α-Diversity (AD) and β-diversity (BD) were calculated, and differential abundance analysis was performed using linear multivariable models (significance: <i>p</i>.adj < .05).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Forty-one patients (MR:MS = 20:21) with a mean age of 7.2 years (±4.6 SD) and 27 age-matched HCs were recruited. No significant differences in AD were found when comparing patients and HCs. Significant positive correlation was found between AD and age (Chao1 <i>p</i>.adj = .0004, Shannon <i>p</i>.adj = .0004, Simpson <i>p</i>.adj = .0028). BD depicted a different bacterial profile in the epilepsy groups compared to HCs (MS vs. HC: Bray–Curtis <i>F</i> = 1.783, <i>p</i> = .001; Jaccard <i>F</i> = 1.24, <i>p</i> = .001; MR vs. HC: Bray–Curtis <i>F</i> = 2.24, <i>p</i> = .001; Jaccard <i>F</i> = 1.364, <i>p</i> = .001). At the genus level, the epilepsy groups were characterized by a significant increase in <i>Hungatella</i> (MS vs. HC: +4.95 log<sub>2</sub> change; MR vs. HC: +6.72 log<sub>2</sub> change); the <i>[Eubacterium] siraeum</i> group changed between the MR and MS subgroups.</p>\n </section>\n \n <section>\n \n <h3> Significance</h3>\n \n <p>Epileptic patients display unique gut metagenomic signatures compared to HCs. Moreover, a different ratio of the butyrate-producing <i>[Eubacterium] siraeum</i> group suggests dissimilarities between patients based on the response to antiseizure medications.</p>\n </section>\n </div>","PeriodicalId":11768,"journal":{"name":"Epilepsia","volume":"66 7","pages":"2268-2284"},"PeriodicalIF":6.6000,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/epi.18367","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epilepsia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/epi.18367","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Dysfunction of the microbiota–gut–brain axis is emerging as a new pathogenic mechanism in epilepsy, potentially impacting on medication response and disease outcome. We investigated the composition of the gut microbiota in a cohort of medication-resistant (MR) and medication-sensitive (MS) pediatric patients with epilepsy.
Methods
Children with epilepsy of genetic and presumed genetic etiologies were evaluated clinically and subgrouped into MR and MS. Age-matched healthy controls (HCs) were also recruited. A food diary was used to evaluate nutritional habits, and the Rome IV questionnaire was used to record gastrointestinal symptoms. The microbiota composition was assessed in stool samples through 16S rRNA. α-Diversity (AD) and β-diversity (BD) were calculated, and differential abundance analysis was performed using linear multivariable models (significance: p.adj < .05).
Results
Forty-one patients (MR:MS = 20:21) with a mean age of 7.2 years (±4.6 SD) and 27 age-matched HCs were recruited. No significant differences in AD were found when comparing patients and HCs. Significant positive correlation was found between AD and age (Chao1 p.adj = .0004, Shannon p.adj = .0004, Simpson p.adj = .0028). BD depicted a different bacterial profile in the epilepsy groups compared to HCs (MS vs. HC: Bray–Curtis F = 1.783, p = .001; Jaccard F = 1.24, p = .001; MR vs. HC: Bray–Curtis F = 2.24, p = .001; Jaccard F = 1.364, p = .001). At the genus level, the epilepsy groups were characterized by a significant increase in Hungatella (MS vs. HC: +4.95 log2 change; MR vs. HC: +6.72 log2 change); the [Eubacterium] siraeum group changed between the MR and MS subgroups.
Significance
Epileptic patients display unique gut metagenomic signatures compared to HCs. Moreover, a different ratio of the butyrate-producing [Eubacterium] siraeum group suggests dissimilarities between patients based on the response to antiseizure medications.
目的:微生物-肠-脑轴功能障碍正在成为癫痫的一种新的致病机制,可能影响药物反应和疾病结局。我们研究了一组耐药(MR)和药物敏感(MS)儿童癫痫患者肠道微生物群的组成。方法:对遗传和推定遗传病因的癫痫患儿进行临床评估,并将其亚组为MR和ms,同时招募年龄匹配的健康对照(hc)。饮食日记用于评估营养习惯,罗马IV问卷用于记录胃肠道症状。通过16S rRNA评估粪便样品中的微生物群组成。计算α-多样性(AD)和β-多样性(BD),采用线性多变量模型进行差异丰度分析(p.adj)结果:41例患者(MR:MS = 20:21),平均年龄7.2岁(±4.6 SD), 27例年龄匹配的hc。在比较患者和hc时,没有发现AD的显著差异。AD与年龄呈显著正相关(Chao1 p.adj =。香农p.adj .形容词;0004,辛普森p.p j = .0028)。与HC相比,BD在癫痫组中描述了不同的细菌谱(MS vs. HC: Bray-Curtis F = 1.783, p = .001;Jaccard F = 1.24, p = .001;MR vs HC: Bray-Curtis F = 2.24, p = .001;Jaccard F = 1.364, p = .001)。在属水平上,癫痫组的特征是Hungatella显著增加(MS vs HC: +4.95 log2变化;MR vs. HC: +6.72 log2变化);[真杆菌]西雷姆组在MR和MS亚组之间发生变化。意义:与hc相比,癫痫患者表现出独特的肠道宏基因组特征。此外,不同比例的产丁酸[真杆菌]西雷姆组表明,基于对抗癫痫药物的反应,患者之间存在差异。
期刊介绍:
Epilepsia is the leading, authoritative source for innovative clinical and basic science research for all aspects of epilepsy and seizures. In addition, Epilepsia publishes critical reviews, opinion pieces, and guidelines that foster understanding and aim to improve the diagnosis and treatment of people with seizures and epilepsy.